bt_bb_section_bottom_section_coverage_image

John Holland

Consultant, Plutus Consulting Group

John has over 30 years experience as President, Managing Director and VP Marketing of Fortune 500 companies (Unilever, Richardson Vicks/P&G, Sara Lee) in North America, UK, Europe and Africa.

He is skilled in CPG marketing, successfully launched new products in Europe, Africa and North America, helping companies to achieve their branding and market penetration goals.

  • Responsible for the worldwide product innovation, rebranding and growth program for a global product line of Sara Lee Corp in 1998.
  • Over many years he has guided businesses in such areas as:
    • Clarity of business Strategy, and performance improvement (ROI)
    • Branding, Product Innovation, Marketing & Sales strategy
    • Organizational goal alignment and employee motivation
    • Business planning and Process management
    • Operational efficiencies

John uses a proprietary diagnostics tool to identify barriers to enhanced performance, and works with ownership to develop strategies and action plans to implement the agreed turnaround plans. This results in increased business value.

John can be reached by email at john@plutuscg.com

bt_bb_section_bottom_section_coverage_image

Sign Up To Receive Our Monthly Execu-Brief®
By signing up for our newsletter, you agree to receive email marketing messages from Robbinex at the submitted email address.
This field is for validation purposes and should be left unchanged.

Yes, but it was more than 1.5 years ago

It may be time to evaluate whether your valuation is still an accurate representation of your business.

Yes, within the last 18 months

We can work with you to update your valuation and determine the next steps to achieve your exit planning goals

No, I don’t want one

We can work with you to update your valuation and determine the next steps to achieve your exit planning goals.

No, but I am considering it !

Robbinex requires a valuation for us to list your business for sale, however, we are willing to consider accepting valuations from other providers. How can we help?